Cerevel Therapeutics is understanding the brain to treat neuroscience diseases. Many diseases are caused by malfunctions of neurocircuitry affecting millions of people worldwide. Cerevel is striving to understand why these deficits in neurocircuitry occur and how they can be treated. Using advancements in chemistry, genomics and proteomics, Cerevel is identifying small molecules that target neuronal receptors to normalize neural network function. Cerevel currently has a diverse pipeline with therapies addressing various neurological disorders including Parkinson’s, Epilepsy and Anxiety in pre-clinical and clinical stages.